Ahlfors C.E. Criteria for exchange transfusion in jaundiced newborns. Pediatrics, 1994.- V. 93.- P. 488-494.

9. Approach to the management of hyperbilirubinemia in term newborn infants. Fetus and Newborn Committee, Canadian Paediatric Society (CPS). A joint statement with the College of Family Physicians of Canada. Paediatrics & Child Health 1999; 4(2): 161-164.

10. Bhutani V.K., Johnson L., Sivieri E.M. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns / Pediatrics 1999.- V. 103.- P. 6-14.

11. Current status of immunoprophylaxis withy anti-D immunoglobulin. Internatiional forum // Vox sanguinis 2003.- V. 85.- P. 328-337.

12. Сramer L.I. Advancement of dermal icterus in the jaundiced newborn. AMJ Dis Child 1969; 118: 454.

13. De Carvalho M, Holl M, Harvey D. Effects of water supplementation on physiological jaundice in breast-fed babies. Arch Dis Child. 1981; 56: 568 –569

14. Ezuthachan S., Newman C. ^Жовтяниці у новонароджених дітей: патофізіологія та сучасні вимоги до їх лікування. // Матеріали міжнародної конференції “Актуальніі проблеми неонатології.” – Львів-Детройт, 1997. – С.9 –21.

15. Entwicklung / F.C. Sitzmann. Kinderheilkunde. Referenzwerte fur das Kindesalter. S. 999.

16. Eggert P., Stick C., Schroder H. On the distributrion of irradiation intensity in phototherapy. Measurements of effective irradiance in an incubator. European Journal of Pediatrics, 1984.- V.142.- P. 58-61.

17. Gottstein R., Cooke R.W.I. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Archives of disease in childhood. Fetal anhd neonatal edition, 2003.- V. 88.- P.F6-F10.

18. Haas J.E. Bile duct and liver pathology in biliary atresia // World Journal of Surgery, 1978. – V.2. – P. 561–569.

19. Hinkes M. T., Cloherty J. P. Neonatal Hyperbilirubinemia // Мanual of Neonatal Care. – 4th ed. /Ed. by J. Cloherty and A. R. Stark. – Philadelрhia, New York: Lippincott – Raven Publishers­, 1998. – P.175–209.

20. Ip S., Chung M., Kulig J. Et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. American Academy of Pediatrics. Technical report. Pediatrics, 2004.- V. 114.- N 1.- _P. 130-153.

21. J. Rau. Wachstum und Hinkes M. T., Cloherty J. P. Neonatal Hyperbilirubinemia // Мanual of Neonatal Care. – 4th ed. /Ed. by J. Cloherty and A. R. Stark. – Philadelрhia, New York: Lippincott – Raven Publishers­, 1998. – P.175–209.

22. Mowat A.P. Disorders of the liver and biliary system // Textbook of Neonatology / Ed. by N.R.C.Roberton. – Sec. edition. - Edinburg-London-Madrid-Melbourne-New York-Tokyo: Churchill Livingstone, 1992. – P. 605–617.

23. Madlon-Kay DJ. Identifying ABO incompatibility in newborns: selective vs automatic testing. J Fam Pract. 1992; 35: 278 –280

24. Maisels M.J. Why use homeopathic doses of phototherapy? Pediatrics, 1996.- V. 98.- P. 283-287.

25. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. American Academy of Pediatrics. Clinical practice guideline. Subcommitee on hyperbilirubinemia // Pediatrics 2004.- V. 114.- N1.- P. 297-316.

26. Grunebaum E, Amir J, Merlob P, Mimouni M, Varsano I. Breast mild jaundice: natural history, familial incidence and late neurodevelopmental outcome of the infant. Eur J Pediatr. 1991 Feb; 150(4): 267-70.

27. Kevy S.V. Blood products used in the newborn // Мanual of Neonatal Care. – 4th ed. /Ed. by J. Cloherty and A. R. Stark. – Philadelрhia, New York: Lippincott – Raven Publishers­, 1998. – P. 478-486.

28. Kristin Melton, Henry T.Akinbi. Neonatal jaundice. The Practical Peer-Reviewed Journal. November 1999, Vol 106 / #6.

29. Mowat A.P. Disorders of the liver and biliary system // Textbook of Neonatology / Ed. by N.R.C.Roberton. – Sec. edition. - Edinburg-London-Madrid-Melbourne-New York-Tokyo: Churchill Livingstone, 1992. – P. 605–617

30. Maisels MJ, Kring EA. Length of stay, jaundice, and hospital readmission. Pediatrics. 1998; 101: 995 –998

31. McKiernan P.J. Neonatal cholestasis. // Seminars in Neonatology, 2002. – V.7– P.153– 165.

32. Newman T. B., Klebanoff M.A. Neonatal hyperbilirubinemia and long-term outcome // Pediatrics. – 1993. – № 92. – P. 651–657.

33. Nicoll A, Ginsburg R, Tripp JH. Supplementary feeding and jaundice in newborns. Acta Paediatr Scand. 1982; 71: 759 –761

34. Newman TB, Liljestrand P, Escobar GJ. Jaundice noted in the first 24 hours after birth in a managed care organization. Arch Pediatr Adolesc Med. 2002; 156: 1244 –1250

35. Newborn Guideline 4: Jaundice in the Healthy Term Newborn. British Columbia Reproductive Care Program.

36. Newborn Services Clinical Guideline: Management of Neonatal Jaundice. New Zeeland 2004.

37. Oh W., Nyson J.E. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics, 2003.- V. 112.- N 4.- P. 773-779.

38. Roberts E.A. The jaundiced baby. // In: Kelly D.A. (ed.). Diseases of the liver and biliary system in children. 1st edn. Oxford, Blackwell, 1999 – P.11–45.

39. S.M. Shapiro. Bilirubin toxicity in the developing nervous system. Pediatric Neurilogy 2003.- V. 29.- N5.- P. 410-421.

40. Stanley Ip, Mei Chung, John Kuling et al. An Evidence-Based Review of Important Issues Concerning Neonatal Hyperbilirubinemia. Pediatrics 2004; 114; 130-153

41. Valaes T. Bilirubin toxicity // Pediatrics. – 1992. – № 89. – P.819— 821.

42. World Health Organisation. Managing Newborn Problems: A guide for doctors, nurses, and midwives. June 2003.

Моісеєнко Р.О.

Дутов Є.М.

Склад робочої групи

по розробці протоколу „Жовтяниця новонароджених”

[1] Нормальний показник рівня білірубіну в пуповинній крові – до 50 мкмоль/л

[2] Наказ МОЗ України №152 від 04.04.2005